Self-driving laboratories: A paradigm shift in nanomedicine development

Nanomedicines have transformed promising therapeutic agents into clinically approved medicines with optimal safety and efficacy profiles. This is exemplified by the mRNA vaccines against COVID-19, which were made possible by lipid nanoparticle technology. Despite the success of nanomedicines to date...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickman, Riley J., Bannigan, Pauric, Bao, Zeqing, Aspuru-Guzik, Alán, Allen, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993483/
https://www.ncbi.nlm.nih.gov/pubmed/37020832
http://dx.doi.org/10.1016/j.matt.2023.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993483/
https://www.ncbi.nlm.nih.gov/pubmed/37020832
http://dx.doi.org/10.1016/j.matt.2023.02.007

Ejemplares similares